Neoadjuvant axitinib may reduce venous tumour thrombus in kidney cancer
Neoadjuvant treatment is medication that is given before surgery to [...]
COVID-19 and cancer: Immunotherapy and immunosuppressive cancer therapies
This review summarises the outcomes of people with COVID-19 taking [...]
Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinoma
MiT family translocation renal cell carcinoma is a rare and [...]
Weight loss with cabozantinib use in patients with metastatic kidney cancer
This recent study looked at the effects of cabozantinib on [...]
Does the time to start first-line treatment influence survival of patients with low risk kidney cancer?
Many patients with low-risk or favourable-risk kidney cancer may have [...]
Reduced starting dose of TKI is comparable to a full dose in metastatic kidney cancer
A study published in the Journal of Hematology Oncology Pharmacy [...]
Nivolumab plus ipilimumab for localised kidney cancer
In a recent phase 3 clinical trial the combination of [...]
Adjuvant nivolumab plus ipilimumab for kidney cancer
Adjuvant therapy is medication that is given after surgery to [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
